Ovid Therapeutics (OVID) Other Accumulated Expenses (2016 - 2022)
Ovid Therapeutics (OVID) reported Other Accumulated Expenses of $139,167 for Q1 2022, down 79.3% from $673,285 a year earlier and down 74.5% from the prior quarter.
Powered by 
Analysis
Ovid Therapeutics (OVID) Other Accumulated Expenses (2016 - 2022) Analysis & Trends
At the end of FY2021, Ovid Therapeutics posted Other Accumulated Expenses of $546,464, up 230.1% from FY2020.
- Other Accumulated Expenses has a five-year compound annual growth rate of 15.4% (FY2016 to FY2021).
- By year, Other Accumulated Expenses came in at $165,536 in FY2020 (-28.7%), $232,095 in FY2019 (+25.5%), $184,923 in FY2018 (-25.0%) and $246,503 in FY2017 (-7.8%).
- Five-year quarterly Other Accumulated Expenses spans a low of $119,940 in Q3 2021 and a high of $1.96 million in Q2 2021.
- Year over year, Other Accumulated Expenses gained in five of the last eight quarters, with growth averaging 116.8%.
- The high point for year-over-year Other Accumulated Expenses in five years was Q2 2021 (growth of 621.0%); the low point was Q1 2022 (a decline of 79.3%).
- Per Business Quant data, the three quarters before Q1 2022 came in at $546,464 (Q4 2021), $119,940 (Q3 2021) and $1.96 million (Q2 2021).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Ovid Therapeutics | 439.72 Mn | 71.74 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2022 | 139,167.00 |
| Dec 31, 2021 | 546,464.00 |
| Sep 30, 2021 | 119,940.00 |
| Jun 30, 2021 | 1.96 Mn |
| Mar 31, 2021 | 673,285.00 |
| Dec 31, 2020 | 165,536.00 |
| Sep 30, 2020 | 274,903.00 |
| Jun 30, 2020 | 271,314.00 |
| Mar 31, 2020 | 248,813.00 |
| Dec 31, 2019 | 232,095.00 |
| Sep 30, 2019 | 236,716.00 |
| Jun 30, 2019 | 168,798.00 |
| Mar 31, 2019 | 148,414.00 |
| Dec 31, 2018 | 184,923.00 |
| Sep 30, 2018 | 169,347.00 |
| Jun 30, 2018 | 142,796.00 |
| Mar 31, 2018 | 150,768.00 |
| Dec 31, 2017 | 246,503.00 |
| Sep 30, 2017 | 157,015.00 |
| Jun 30, 2017 | 124,320.00 |
API Access
Ovid Therapeutics Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=OVID&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "OVID", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=OVID&period=max&api_key=YOUR_API_KEY");
const data = await res.json();